Table of Content

1 Small Volume Parenterals (SVP) Market Overview
1.1 Product Overview and Scope of Small Volume Parenterals (SVP)
1.2 Small Volume Parenterals (SVP) Segment by Type
1.2.1 Global Small Volume Parenterals (SVP) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Ampules
1.2.3 Vials
1.2.4 Prefilled Syringes
1.3 Small Volume Parenterals (SVP) Segment by Application
1.3.1 Global Small Volume Parenterals (SVP) Sales Comparison by Application: (2021-2027)
1.3.2 Local Anesthetics
1.3.3 Vaccines
1.3.4 Other
1.4 Global Small Volume Parenterals (SVP) Market Size Estimates and Forecasts
1.4.1 Global Small Volume Parenterals (SVP) Revenue 2016-2027
1.4.2 Global Small Volume Parenterals (SVP) Sales 2016-2027
1.4.3 Small Volume Parenterals (SVP) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Small Volume Parenterals (SVP) Market Competition by Manufacturers
2.1 Global Small Volume Parenterals (SVP) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Small Volume Parenterals (SVP) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Small Volume Parenterals (SVP) Manufacturing Sites, Area Served, Product Type
2.5 Small Volume Parenterals (SVP) Market Competitive Situation and Trends
2.5.1 Small Volume Parenterals (SVP) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Small Volume Parenterals (SVP) Players Market Share by Revenue
2.5.3 Global Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Small Volume Parenterals (SVP) Retrospective Market Scenario by Region
3.1 Global Small Volume Parenterals (SVP) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Small Volume Parenterals (SVP) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.3.1 North America Small Volume Parenterals (SVP) Sales by Country
3.3.2 North America Small Volume Parenterals (SVP) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.4.1 Europe Small Volume Parenterals (SVP) Sales by Country
3.4.2 Europe Small Volume Parenterals (SVP) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Small Volume Parenterals (SVP) Market Facts & Figures by Region
3.5.1 Asia Pacific Small Volume Parenterals (SVP) Sales by Region
3.5.2 Asia Pacific Small Volume Parenterals (SVP) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.6.1 Latin America Small Volume Parenterals (SVP) Sales by Country
3.6.2 Latin America Small Volume Parenterals (SVP) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Small Volume Parenterals (SVP) Market Facts & Figures by Country
3.7.1 Middle East and Africa Small Volume Parenterals (SVP) Sales by Country
3.7.2 Middle East and Africa Small Volume Parenterals (SVP) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Small Volume Parenterals (SVP) Historic Market Analysis by Type
4.1 Global Small Volume Parenterals (SVP) Sales Market Share by Type (2016-2021)
4.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Type (2016-2021)
4.3 Global Small Volume Parenterals (SVP) Price by Type (2016-2021)

5 Global Small Volume Parenterals (SVP) Historic Market Analysis by Application
5.1 Global Small Volume Parenterals (SVP) Sales Market Share by Application (2016-2021)
5.2 Global Small Volume Parenterals (SVP) Revenue Market Share by Application (2016-2021)
5.3 Global Small Volume Parenterals (SVP) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Allergan
6.1.1 Allergan Corporation Information
6.1.2 Allergan Description and Business Overview
6.1.3 Allergan Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Allergan Small Volume Parenterals (SVP) Product Portfolio
6.1.5 Allergan Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Bayer Small Volume Parenterals (SVP) Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 GSK Small Volume Parenterals (SVP) Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 J&J
6.4.1 J&J Corporation Information
6.4.2 J&J Description and Business Overview
6.4.3 J&J Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 J&J Small Volume Parenterals (SVP) Product Portfolio
6.4.5 J&J Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Pfizer Small Volume Parenterals (SVP) Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Teva Small Volume Parenterals (SVP) Product Portfolio
6.6.5 Teva Recent Developments/Updates
6.7 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Small Volume Parenterals (SVP) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Novartis Small Volume Parenterals (SVP) Product Portfolio
6.7.5 Novartis Recent Developments/Updates

7 Small Volume Parenterals (SVP) Manufacturing Cost Analysis
7.1 Small Volume Parenterals (SVP) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Small Volume Parenterals (SVP)
7.4 Small Volume Parenterals (SVP) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Small Volume Parenterals (SVP) Distributors List
8.3 Small Volume Parenterals (SVP) Customers

9 Small Volume Parenterals (SVP) Market Dynamics
9.1 Small Volume Parenterals (SVP) Industry Trends
9.2 Small Volume Parenterals (SVP) Growth Drivers
9.3 Small Volume Parenterals (SVP) Market Challenges
9.4 Small Volume Parenterals (SVP) Market Restraints

10 Global Market Forecast
10.1 Small Volume Parenterals (SVP) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Small Volume Parenterals (SVP) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Small Volume Parenterals (SVP) by Type (2022-2027)
10.2 Small Volume Parenterals (SVP) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Small Volume Parenterals (SVP) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Small Volume Parenterals (SVP) by Application (2022-2027)
10.3 Small Volume Parenterals (SVP) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Small Volume Parenterals (SVP) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Small Volume Parenterals (SVP) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Small Volume Parenterals (SVP) Sales (K Doses) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Small Volume Parenterals (SVP) Sales (K Doses) Comparison by Application (2021-2027)
Table 3. Global Small Volume Parenterals (SVP) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Small Volume Parenterals (SVP) Covered in This Study
Table 5. Global Small Volume Parenterals (SVP) Sales (K Doses) of Key Manufacturers (2016-2021)
Table 6. Global Small Volume Parenterals (SVP) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Small Volume Parenterals (SVP) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Small Volume Parenterals (SVP) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Small Volume Parenterals (SVP) Average Price (USD/Dose) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Small Volume Parenterals (SVP) Manufacturing Sites and Area Served
Table 11. Manufacturers Small Volume Parenterals (SVP) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Small Volume Parenterals (SVP) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Small Volume Parenterals (SVP) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Small Volume Parenterals (SVP) Sales by Region (2016-2021) & (K Doses)
Table 16. Global Small Volume Parenterals (SVP) Sales Market Share by Region (2016-2021)
Table 17. Global Small Volume Parenterals (SVP) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Small Volume Parenterals (SVP) Sales by Country (2016-2021) & (K Doses)
Table 19. North America Small Volume Parenterals (SVP) Sales Market Share by Country (2016-2021)
Table 20. North America Small Volume Parenterals (SVP) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Small Volume Parenterals (SVP) Revenue Market Share by Country (2016-2021)
Table 22. Europe Small Volume Parenterals (SVP) Sales by Country (2016-2021) & (K Doses)
Table 23. Europe Small Volume Parenterals (SVP) Sales Market Share by Country (2016-2021)
Table 24. Europe Small Volume Parenterals (SVP) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Small Volume Parenterals (SVP) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Small Volume Parenterals (SVP) Sales by Region (2016-2021) & (K Doses)
Table 27. Asia Pacific Small Volume Parenterals (SVP) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Small Volume Parenterals (SVP) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Small Volume Parenterals (SVP) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Small Volume Parenterals (SVP) Sales by Country (2016-2021) & (K Doses)
Table 31. Latin America Small Volume Parenterals (SVP) Sales Market Share by Country (2016-2021)
Table 32. Latin America Small Volume Parenterals (SVP) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Small Volume Parenterals (SVP) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Small Volume Parenterals (SVP) Sales by Country (2016-2021) & (K Doses)
Table 35. Middle East and Africa Small Volume Parenterals (SVP) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Small Volume Parenterals (SVP) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Small Volume Parenterals (SVP) Revenue Market Share by Country (2016-2021)
Table 38. Global Small Volume Parenterals (SVP) Sales (K Doses) by Type (2016-2021)
Table 39. Global Small Volume Parenterals (SVP) Sales Market Share by Type (2016-2021)
Table 40. Global Small Volume Parenterals (SVP) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Small Volume Parenterals (SVP) Revenue Share by Type (2016-2021)
Table 42. Global Small Volume Parenterals (SVP) Price (USD/Dose) by Type (2016-2021)
Table 43. Global Small Volume Parenterals (SVP) Sales (K Doses) by Application (2016-2021)
Table 44. Global Small Volume Parenterals (SVP) Sales Market Share by Application (2016-2021)
Table 45. Global Small Volume Parenterals (SVP) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Small Volume Parenterals (SVP) Revenue Share by Application (2016-2021)
Table 47. Global Small Volume Parenterals (SVP) Price (USD/Dose) by Application (2016-2021)
Table 48. Allergan Corporation Information
Table 49. Allergan Description and Business Overview
Table 50. Allergan Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 51. Allergan Small Volume Parenterals (SVP) Product
Table 52. Allergan Recent Developments/Updates
Table 53. Bayer Corporation Information
Table 54. Bayer Description and Business Overview
Table 55. Bayer Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 56. Bayer Small Volume Parenterals (SVP) Product
Table 57. Bayer Recent Developments/Updates
Table 58. GSK Corporation Information
Table 59. GSK Description and Business Overview
Table 60. GSK Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 61. GSK Small Volume Parenterals (SVP) Product
Table 62. GSK Recent Developments/Updates
Table 63. J&J Corporation Information
Table 64. J&J Description and Business Overview
Table 65. J&J Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 66. J&J Small Volume Parenterals (SVP) Product
Table 67. J&J Recent Developments/Updates
Table 68. Pfizer Corporation Information
Table 69. Pfizer Description and Business Overview
Table 70. Pfizer Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 71. Pfizer Small Volume Parenterals (SVP) Product
Table 72. Pfizer Recent Developments/Updates
Table 73. Teva Corporation Information
Table 74. Teva Description and Business Overview
Table 75. Teva Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 76. Teva Small Volume Parenterals (SVP) Product
Table 77. Teva Recent Developments/Updates
Table 78. Novartis Corporation Information
Table 79. Novartis Description and Business Overview
Table 80. Novartis Small Volume Parenterals (SVP) Sales (K Doses), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2016-2021)
Table 81. Novartis Small Volume Parenterals (SVP) Product
Table 82. Novartis Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Small Volume Parenterals (SVP) Distributors List
Table 86. Small Volume Parenterals (SVP) Customers List
Table 87. Small Volume Parenterals (SVP) Market Trends
Table 88. Small Volume Parenterals (SVP) Growth Drivers
Table 89. Small Volume Parenterals (SVP) Market Challenges
Table 90. Small Volume Parenterals (SVP) Market Restraints
Table 91. Global Small Volume Parenterals (SVP) Sales Forecast by Type (2022-2027) & (K Doses)
Table 92. Global Small Volume Parenterals (SVP) Sales Market Share Forecast by Type (2022-2027)
Table 93. Global Small Volume Parenterals (SVP) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 94. Global Small Volume Parenterals (SVP) Revenue Market Share Forecast by Type (2022-2027)
Table 95. Global Small Volume Parenterals (SVP) Sales Forecast by Application (2022-2027) & (K Doses)
Table 96. Global Small Volume Parenterals (SVP) Sales Market Share Forecast by Application (2022-2027)
Table 97. Global Small Volume Parenterals (SVP) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 98. Global Small Volume Parenterals (SVP) Revenue Market Share Forecast by Application (2022-2027)
Table 99. Global Small Volume Parenterals (SVP) Sales Forecast by Region (2022-2027) & (K Doses)
Table 100. Global Small Volume Parenterals (SVP) Sales Market Share Forecast by Region (2022-2027)
Table 101. Global Small Volume Parenterals (SVP) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 102. Global Small Volume Parenterals (SVP) Revenue Market Share Forecast by Region (2022-2027)
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Small Volume Parenterals (SVP)
Figure 2. Global Small Volume Parenterals (SVP) Market Share by Type in 2020 & 2027
Figure 3. Ampules Product Picture
Figure 4. Vials Product Picture
Figure 5. Prefilled Syringes Product Picture
Figure 6. Global Small Volume Parenterals (SVP) Market Share by Application in 2020 & 2027
Figure 7. Local Anesthetics
Figure 8. Vaccines
Figure 9. Other
Figure 10. Global Small Volume Parenterals (SVP) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Small Volume Parenterals (SVP) Market Size 2016-2027 (US$ Million)
Figure 12. Global Small Volume Parenterals (SVP) Sales 2016-2027 (K Doses)
Figure 13. Global Small Volume Parenterals (SVP) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Small Volume Parenterals (SVP) Sales Share by Manufacturers in 2020
Figure 15. Global Small Volume Parenterals (SVP) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Small Volume Parenterals (SVP) Players: Market Share by Revenue in 2020
Figure 17. Small Volume Parenterals (SVP) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Small Volume Parenterals (SVP) Sales Market Share by Region (2016-2021)
Figure 19. Global Small Volume Parenterals (SVP) Sales Market Share by Region in 2020
Figure 20. Global Small Volume Parenterals (SVP) Revenue Market Share by Region (2016-2021)
Figure 21. Global Small Volume Parenterals (SVP) Revenue Market Share by Region in 2020
Figure 22. U.S. Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Small Volume Parenterals (SVP) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Small Volume Parenterals (SVP) by Type (2016-2021)
Figure 47. Sales Market Share of Small Volume Parenterals (SVP) by Application (2016-2021)
Figure 48. Sales Market Share of Small Volume Parenterals (SVP) by Application in 2020
Figure 49. Revenue Share of Small Volume Parenterals (SVP) by Application (2016-2021)
Figure 50. Revenue Share of Small Volume Parenterals (SVP) by Application in 2020
Figure 51. Manufacturing Cost Structure of Small Volume Parenterals (SVP)
Figure 52. Manufacturing Process Analysis of Small Volume Parenterals (SVP)
Figure 53. Small Volume Parenterals (SVP) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed